| Management of hyperglycemia in type 2 diabetes, 2018. A consensus report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD) MJ Davies, DA D’Alessio, J Fradkin, WN Kernan, C Mathieu, G Mingrone, ... Diabetes care 41 (12), 2669, 2018 | 4358 | 2018 |
| Bariatric surgery versus conventional medical therapy for type 2 diabetes G Mingrone, S Panunzi, A De Gaetano, C Guidone, A Iaconelli, L Leccesi, ... New England Journal of Medicine 366 (17), 1577-1585, 2012 | 2453 | 2012 |
| 2019 update to: management of hyperglycemia in type 2 diabetes, 2018. A consensus report by the American Diabetes Association (ADA) and the European Association for the Study … JB Buse, DJ Wexler, A Tsapas, P Rossing, G Mingrone, C Mathieu, ... Diabetes care 43 (2), 487-493, 2020 | 1921 | 2020 |
| Bariatric surgery versus non-surgical treatment for obesity: a systematic review and meta-analysis of randomised controlled trials VL Gloy, M Briel, DL Bhatt, SR Kashyap, PR Schauer, G Mingrone, ... Bmj 347, 2013 | 1584 | 2013 |
| Bariatric–metabolic surgery versus conventional medical treatment in obese patients with type 2 diabetes: 5 year follow-up of an open-label, single-centre, randomised … G Mingrone, S Panunzi, A De Gaetano, C Guidone, A Iaconelli, G Nanni, ... The Lancet 386 (9997), 964-973, 2015 | 1414 | 2015 |
| The mechanism of diabetes control after gastrointestinal bypass surgery reveals a role of the proximal small intestine in the pathophysiology of type 2 diabetes F Rubino, A Forgione, DE Cummings, M Vix, D Gnuli, G Mingrone, ... Annals of surgery 244 (5), 741-749, 2006 | 1349 | 2006 |
| Insulin resistance and hypersecretion in obesity E Ferrannini, A Natali, P Bell, P Cavallo-Perin, N Lalic, G Mingrone The Journal of clinical investigation 100 (5), 1166-1173, 1997 | 1263 | 1997 |
| Practical recommendations for the management of diabetes in patients with COVID-19 SR Bornstein, F Rubino, K Khunti, G Mingrone, D Hopkins, AL Birkenfeld, ... The lancet Diabetes & endocrinology 8 (6), 546-550, 2020 | 1107 | 2020 |
| Management of hyperglycemia in type 2 diabetes, 2022. A consensus report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD) MJ Davies, VR Aroda, BS Collins, RA Gabbay, J Green, NM Maruthur, ... Diabetes care 45 (11), 2753-2786, 2022 | 991 | 2022 |
| Joint international consensus statement for ending stigma of obesity F Rubino, RM Puhl, DE Cummings, RH Eckel, DH Ryan, JI Mechanick, ... Nature medicine 26 (4), 485-497, 2020 | 958 | 2020 |
| New-onset diabetes in Covid-19 F Rubino, SA Amiel, P Zimmet, G Alberti, S Bornstein, RH Eckel, ... New England Journal of Medicine 383 (8), 789-790, 2020 | 922 | 2020 |
| Management of hyperglycaemia in type 2 diabetes, 2022. A consensus report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD) MJ Davies, VR Aroda, BS Collins, RA Gabbay, J Green, NM Maruthur, ... Diabetologia 65 (12), 1925-1966, 2022 | 646 | 2022 |
| Insulin resistance in morbid obesity: reversal with intramyocellular fat depletion AV Greco, G Mingrone, A Giancaterini, M Manco, M Morroni, S Cinti, ... Diabetes 51 (1), 144-151, 2002 | 564 | 2002 |
| Mechanisms of recovery from type 2 diabetes after malabsorptive bariatric surgery C Guidone, M Manco, E Valera-Mora, A Iaconelli, D Gniuli, A Mari, ... Diabetes 55 (7), 2025-2031, 2006 | 520 | 2006 |
| Expression of Mfn2, the Charcot-Marie-Tooth Neuropathy Type 2A Gene, in Human Skeletal Muscle: Effects of Type 2 Diabetes, Obesity, Weight Loss, and the … D Bach, D Naon, S Pich, FX Soriano, N Vega, J Rieusset, M Laville, ... Diabetes 54 (9), 2685-2693, 2005 | 487 | 2005 |
| The trans-ancestral genomic architecture of glycemic traits J Chen, CN Spracklen, G Marenne, A Varshney, LJ Corbin, J Luan, ... Nature genetics 53 (6), 840-860, 2021 | 485 | 2021 |
| Endocrine and metabolic link to coronavirus infection SR Bornstein, R Dalan, D Hopkins, G Mingrone, BO Boehm Nature Reviews Endocrinology 16 (6), 297-298, 2020 | 478 | 2020 |
| Glucagon‐like peptide‐1 receptor activation stimulates hepatic lipid oxidation and restores hepatic signalling alteration induced by a high‐fat diet in nonalcoholic steatohepatitis G Svegliati‐Baroni, S Saccomanno, C Rychlicki, L Agostinelli, ... Liver International 31 (9), 1285-1297, 2011 | 476 | 2011 |
| Metabolic surgery versus conventional medical therapy in patients with type 2 diabetes: 10-year follow-up of an open-label, single-centre, randomised controlled trial G Mingrone, S Panunzi, A De Gaetano, C Guidone, A Iaconelli, E Capristo, ... The Lancet 397 (10271), 293-304, 2021 | 422 | 2021 |
| Post-COVID-19 global health strategies: the need for an interdisciplinary approach Aging clinical and experimental research 32 (8), 1613-1620, 2020 | 350 | 2020 |
